0001209191-20-046963.txt : 20200817 0001209191-20-046963.hdr.sgml : 20200817 20200817163929 ACCESSION NUMBER: 0001209191-20-046963 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200813 FILED AS OF DATE: 20200817 DATE AS OF CHANGE: 20200817 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Stalfort Sean CENTRAL INDEX KEY: 0001709418 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38529 FILM NUMBER: 201110751 MAIL ADDRESS: STREET 1: C/O DOVA PHARMACEUTICALS, INC. STREET 2: 240 LEIGH FARM ROAD, SUITE 245 CITY: DURHAM STATE: NC ZIP: 27707 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Verrica Pharmaceuticals Inc. CENTRAL INDEX KEY: 0001660334 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 463137900 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 10 NORTH HIGH STREET STREET 2: SUITE 200 CITY: WEST CHESTER STATE: PA ZIP: 19380 BUSINESS PHONE: 484-453-3300 MAIL ADDRESS: STREET 1: 10 NORTH HIGH STREET STREET 2: SUITE 200 CITY: WEST CHESTER STATE: PA ZIP: 19380 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-08-13 0 0001660334 Verrica Pharmaceuticals Inc. VRCA 0001709418 Stalfort Sean C/O VERRICA PHARMACEUTICALS INC. 10 NORTH HIGH STREET, SUITE 200 WEST CHESTER PA 19380 1 0 0 0 Common Stock 2020-08-13 4 P 0 15550 6.45 A 446410 D Common Stock 2020-08-14 4 P 0 15700 6.38 A 462110 D The price reported is a weighted average purchase price. The shares were purchased in multiple transactions at prices ranging from $6.24 to $6.55, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnotes (1) and (2). The price reported is a weighted average purchase price. The shares were purchased in multiple transactions at prices ranging from $6.08 to $6.65, inclusive. /s/ Mark Ballantyne, Attorney-in-Fact 2020-08-17